NCT00908505

Brief Summary

The purpose of this study is to compare the effectiveness of different mucous clearance techniques in cystic fibrosis patients

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2009

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2009

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 27, 2009

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2009

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

May 27, 2009

Status Verified

May 1, 2009

Enrollment Period

2 years

First QC Date

May 19, 2009

Last Update Submit

May 26, 2009

Conditions

Cystic Fibrosis

Keywords

Cystic fibrosisphysiotherapypulmonary function test

Outcome Measures

Primary Outcomes (1)

  • Pulmonary function test

    1 hour

Study Arms (1)

physiotherapy

EXPERIMENTAL
Procedure: physiotherapy

Interventions

physiotherapyPROCEDURE

physiotherapy either by biphasic cuirass ventilator or physiotherapist

physiotherapy

Eligibility Criteria

Age7 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • CF patients over 7 years old

You may not qualify if:

  • Hemoptysis
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hadassah Medical Organization

Jerusalem, 91240, Israel

Location

MeSH Terms

Conditions

Cystic Fibrosis

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Officials

  • David Shoseyov, MD

    Hadassah Medical Organization

    PRINCIPAL INVESTIGATOR

Central Study Contacts

David Shoseyov, MD

CONTACT

972-2-5844430shoseyov@hadassah.org.il

Hadas Lemberg, PhD

CONTACT

972 2 6777572lhadas@hadassah.org.il

Study Design

Study Type
interventional
Phase
not applicable
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 19, 2009

First Posted

May 27, 2009

Study Start

July 1, 2009

Primary Completion

July 1, 2011

Study Completion

December 1, 2011

Last Updated

May 27, 2009

Record last verified: 2009-05

Locations

IL(1)